BONJELA

This brand name is authorized in Hong Kong SAR China, Ireland, Malta, Singapore, South Africa, UK.

Active ingredients

The drug BONJELA contains a combination of these active pharmaceutical ingredients (APIs):

1	Choline salicylate UNII KD510K1IQW - CHOLINE SALICYLATE
	Choline salicylate is an anti-inflammatory and antipyretic medication. It is often used in oral gel form for the relief of pain, discomfort, and inflammation caused by common mouth ulcers, cold sores, denture and sore spots, as well as mouth ulcers, and sore spots because of orthodontic devices.
	Read more about Choline salicylate
2	Alkyldimethylbenzylammonium chloride UNII 85474O1N9D - CETALKONIUM CHLORIDE
	Read more about Alkyldimethylbenzylammonium chloride

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BONJELA Gel	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A01AD11	Various	A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations → A01AD Other agents for local oral treatment
Discover more medicines within A01AD11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
GB	Medicines & Healthcare Products Regulatory Agency	26797
HK	Department of Health Drug Office	37437
MT	Medicines Authority	MA096/00801
SG	Health Sciences Authority	04303P
ZA	Health Products Regulatory Authority	S/16.4/372